Product Description
Mouse Anti S-AdenosylHomocysteine (SAH) Clone 844-1 | MA00305 | Arthus Biosystems
Product name
Mouse anti-SAH 5a/b
Catalog Number
MA00305-50/100
Description
Mouse monoclonal antibody against S-Adenosylhomocysteine [844-1]
Specificity
MA00305 shows the following reactivities with related compounds: S-Adenosylhomocysteine: 100%, S-Adenosylmethionine: -2.6%, Adenosine: < 1%, Homocysteine: < 1%, L-Cysteine: < 1%, Glutathione: < 1%, L-Cystathionine: < 1%, Methythioadenosine (MTA): < 5%, ADP (adenosine diphosphate): < 1%, ATP (adenosine triphosphate): < 1%.
Immunogen
S-Adenosylhomocysteine conjugated to BSA
Properties
Form
Liquid
Storage instructions
Store at 4°C, -20°C for long term storage
Storage buffer
PBS 10mM pH7.4 (NaCI 150mM), Sodium azide 0.02%, BSA 10mg/m1 or PBS 10mM, pH7.4 (NaCI 150mM), Sodium azide 0.02%, Glycerol 50%, BSA 10mg/m1
Purity
>95% Purified from mouse ascites fluid by affinity chromatography
Clonality
Monoclonal
Clone number
844-1
Immunoglobin isotype
IgG2a
Affinity
Ka = 7.05 x 109L/mol( 1.42 x 10-19M )
Research Areas
- Methylation of biomolecules (DNA, RNA, proteins, hormones, neurotransmitters, etc.)
- One-carbon metabolism
- Signal Transduction
- Metabolism
- Pathways and Processes Cancers
- Arthritis
- Heart diseases
- Neurodegenerative diseases Atherosclerosis
- Liver diseases
- Kidney diseases
Applications
The use of MA00305 in the following tested applications has been tested. The application notes include recommended starting dilutions. Optimal dilutions/concentrations should be determined by the end user. Higher dilution than suggested maybe used in IHC and IF. The product may be used in other not-yet-tested applications.
Notes
- cELISA: 1:30,000/36,000
- FCM: 1:300
- IHC: 1:300
Target
S-adenosylhomocysteine is a competitive inhibitor of S-adenosylmethionine-dependant methyl transferase reactions. Therefore, it plays a key role in the control of methylation via regulation of the intracellular concentration of S-adenosylhomocysteine.
Cellular localization
Cytoplasm, nuclear
Figure 1: Immunohistochemistry staining was performed using MA00305 with benign liver tissue adjacent to liver cancer. Brown areas indicated strong positive staining in nuclear and cytoplasmic areas (x400).